Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 10/30/2025 5:19:16 PM
Board Marks: 394
Posts Today: 0
Board Views Today: 1777
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
Plotinus
08/08/2025 12:22:53 PM
Quite a fascinating, well engineered
(9)
Evil Rabbit
08/08/2025 12:08:51 PM
Dr. Jay has been permanent CEO since
(4)
hoops
08/08/2025 10:06:48 AM
Dr. Jay has been permanent CEO since
(13)
KenChowder
08/08/2025 9:40:10 AM
Thank you, Respert. We can always count
(4)
Respert24
08/08/2025 7:57:49 AM
It's an insightful look at how these
(18)
biloxiblues
08/08/2025 6:49:11 AM
This is what it looks like behind the
(15)
KenChowder
08/08/2025 3:26:35 AM
Study of an aggressive cancer suggests
(10)
Mr3Putt
08/07/2025 7:16:35 PM
They had a good run with the
(4)
sean007
08/07/2025 6:23:57 PM
Literally saying "We are in a quiet
(7)
Evil Rabbit
08/07/2025 5:58:23 PM
Theyve long been overly terrified of
(9)
cardamine
08/07/2025 5:27:35 PM
side note: they can definitely legally
(5)
sean007
08/07/2025 2:38:37 PM
"Gentle mercies of the previous
(2)
Evil Rabbit
08/07/2025 2:36:52 PM
Okay, lets bench the FOR and AGAINST
(12)
Niele
08/07/2025 2:05:33 PM
Thanks to all the medical experts here
(3)
KenChowder
08/07/2025 2:04:48 PM
The last FDA was corrupt and
(13)
sean007
08/07/2025 1:35:41 PM
Bashful...DOC...DOPEY...grumpy...happy..
(2)
Jake2212
08/07/2025 12:35:21 PM
ER: Of course many things go from bad
(25)
Evil Rabbit
08/07/2025 12:10:55 PM
The premise of your argument implies
(9)
Jake2212
08/07/2025 11:14:44 AM
ohm: I am surprised by your repeated
(23)
skezan
08/07/2025 9:10:54 AM
I was browsing the annual report to see
SamaGong
08/07/2025 9:05:45 AM
Ohm, there are many patients and their
(19)
KenChowder
08/07/2025 9:03:31 AM
Yes, a stock that moves 5 or 10 percent
(1)
Boatbuilder
08/07/2025 8:40:31 AM
Yeah, I make a killing day trading a
(2)
My69z
08/07/2025 7:30:37 AM
& Rogex broke down those that were in
(7)
KenChowder
08/07/2025 6:53:15 AM
Here's another paper that supports the
(8)
My69z
08/07/2025 5:35:06 AM
From 2020 with Pestell -- " In analysis
(7)
My69z
08/07/2025 5:19:39 AM
"For example, CCR5 is overexpressed in
(8)
KenChowder
08/07/2025 4:29:18 AM
Not sure Mr./Ms. Rug's figures are
(7)
Niele
08/07/2025 3:31:50 AM
Posted by Artsakh_Rug on Reddit.
(9)
My69z
08/07/2025 12:43:30 AM
Don't let it fade away how fortunate an
(18)
My69z
08/06/2025 9:59:40 PM
My bet based on Our Science: Will
(6)
ohm20
08/06/2025 9:38:23 PM
I just wonder if our new FDA - if they
(16)
USS JOHNSTON
08/06/2025 9:06:38 PM
Thanks, brentie. Question: Is it
(8)
Figgs
08/06/2025 8:36:41 PM
But a scam is two way street, so
(3)
ohm20
08/06/2025 7:32:47 PM
I have come to the conclusion that
(17)
sean007
08/06/2025 7:14:54 PM
This appears to be an excellent window
(6)
sean007
08/06/2025 5:21:41 PM
Occam's razor to the
(1)
Figgs
08/06/2025 5:13:39 PM
So if nobody knows anything, why are
(7)
Evil Rabbit
08/06/2025 4:35:55 PM
Plus a generous seasoning of
(7)
brentie
08/06/2025 4:32:57 PM
Top 5 Pharma Startups Tackling Sexually
(10)
Boatbuilder
08/06/2025 4:27:32 PM
Not really, its just the simplest
(2)
sean007
08/06/2025 3:43:11 PM
..."IF patients are progressing in (the
(1)
FKAdamF.
08/06/2025 2:51:55 PM
A very appropriate response after the
(3)
Camp2800
08/06/2025 2:49:55 PM
Leronlimab - Merck Could Merck be slow
(3)
MidnightRider
08/06/2025 2:40:58 PM
Can't we all just get
(4)
Evil Rabbit
08/06/2025 12:50:50 PM
Nobody here knows anything. Theres
(7)
Katangolo
08/06/2025 12:47:44 PM
Cool. Im done. Ill go silent and
(1)
Katangolo
08/06/2025 12:47:09 PM
Sorry Ken, youre right. Siri cant
(1)
Boatbuilder
08/06/2025 12:33:03 PM
Nobody here knows anything. We are all
(10)
skezan
08/06/2025 11:34:26 AM
Groundhog Day again.
(1)
Newer
Older
Recent Articles
Bioretec Ltd Adjusts H1 Report: Financial Highlights and Outlook
Tetragon Financial Group Reveals September 2025 Insights
Bioretec Ltd Updates Financial Report Details for 2025
Loomis Reports Robust Performance in Q3 2025 with Growth
Investments from Optiver and Qube Strengthen McKay Brothers
Strategic Investments by Optiver and QRT Propel McKay Brothers
Mycenax Partners with RIN Institute to Transform ADC Technology
Transforming Enterprises: FastGPT's No-code AI Solutions for 2025
Corbus Pharmaceuticals Moves Forward with Public Offering
S&P 500 Achieves Historic Winning Streak and Market Insights
Key Challenges Highlighted by Michael Saylor for Growth Strategy
Ecer.com Launches Innovative AI Marketplace Strategy for Trade
Bioretec Ltd Revises 2025 Half-Year Report with Key Updates
DigitalXForce Achieves Prestigious Leader Status in IDC Assessment
Danske Bank Sees Positive Trends and Growth for 2025
Sampo plc's Latest Share Buyback Program and Results
Exciting Developments in Kudu Well Appraisal by BW Energy
Aalberts N.V. Strengthens Position with GVT Acquisition
Nxera Pharma's Innovations and Financial Report for 2025
Nxera Pharma Expands Manufacturing to Meet Growing Demand for QUVIVIQ®
Vistin Pharma Reports Strong Q3 Results and Market Growth
Corbus Pharmaceuticals Sets Price for New Stock Offering
Introducing a New Executive Team Member at Realkredit Danmark
Aalberts Enhances Market Position Through Latest Acquisition
Exploring the Future of Green Hydrogen Development
Aker Solutions ASA Sees Revenue Boost in Third Quarter
Aker Solutions Reports Strong Performance in Q3 2025
Aker Solutions’ Record Growth and Promising Future Outlook
Investigation Launched into Conduent's Major Data Breach Event
Vallourec Secures Groundbreaking Contract for Deepwater Project
Essential Patient Inquiries for Portable X-Ray Scheduling
Exploring Affordable Coastal Living Alternatives Near Beaches
Intensity Therapeutics Sees Dip After Surging to New Heights
Marimekko's Strategic Growth and Operations in 2025
SCOR Reports Impressive Q3 2025 Earnings and Growth Metrics
SPIE Reports Robust Growth and Strategic Acquisitions in 2025
Trifork Group Achieves 4.7% Revenue Growth in Q3 Growth Report
Ekspress Grupp’s Revenue Growth and Future Strategies Unveiled
Marimekko Sees Growth in Q3 Revenue and Profits for 2025
Syensqo's Strategic Shift: Selling Oil & Gas Division to SNF
Elis Expands its Reach in Germany with New Acquisition Deal
Biotalys' EVOCA Biofungicide Nears EPA Approval, Changing Crop Protection
Hyundai and NVIDIA Unite for Advanced AI Innovation
Transforming Manufacturing: NVIDIA and SK Group's AI Collaboration
NVIDIA and Samsung Launch Revolutionary AI Manufacturing Factory
NVIDIA and South Korea Join Forces to Revolutionize AI Landscape
Vallourec Secures Major Offshore Contract with TechnipFMC
SCOR Achieves Remarkable Q3 2025 with Strong Net Income
Realsee Partners with Linkhome to Transform Real Estate with AI
Revolutionizing Retirement: How Physicians Are Investing Wisely